Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (501-510 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|February 26, 2020
Understanding the human antibody repertoireAnthony R Rees
Mabs|January 12, 2020
T cell epitope mapping of secukinumab and ixekizumab in healthy donorsSebastian Spindeldreher, Anette Karle, Evelyne Correia, et al.
Mabs|November 18, 2020
Selection and verification of antibodies against the cytoplasmic domain of M2 of influenza, a transmembrane proteinNileena Velappan, Sofiya Micheva-Viteva, Samantha H Adikari, et al.
Mabs|November 2, 2020
Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors <i>in vivo</i>Lisa Nadal, Riccardo Corbellari, Alessandra Villa, et al.
Mabs|September 21, 2020
An accelerated surface-mediated stress assay of antibody instability for developability studiesMarie R G Kopp, Adriana-Michelle Wolf Pérez, Marta Virginia Zucca, et al.
Mabs|September 7, 2020
Engineered Fc-glycosylation switch to eliminate antibody effector functionQun Zhou, Julie Jaworski, Yanfeng Zhou, et al.
Mabs|January 7, 2020
Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptorXiaoshan Min, Junming Yie, Jinghong Wang, et al.
Mabs|March 20, 2020
Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumorsEric Hatterer, Xavier Chauchet, Françoise Richard, et al.
Mabs|March 14, 2020
Interaction analysis of glycoengineered antibodies with CD16a: a native mass spectrometry approachJoanna Hajduk, Cyrill Brunner, Sebastian Malik, et al.
Mabs|January 26, 2020
<i>In situ</i> antibody phage display yields optimal inhibitors of integrin α11/β1Eugenio Gallo, Abdellali Kelil, Peter E Bayliss, et al.
Pageof 184

Showing results (501-510 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|February 26, 2020
Understanding the human antibody repertoireAnthony R Rees
Mabs|January 12, 2020
T cell epitope mapping of secukinumab and ixekizumab in healthy donorsSebastian Spindeldreher, Anette Karle, Evelyne Correia, et al.
Mabs|November 18, 2020
Selection and verification of antibodies against the cytoplasmic domain of M2 of influenza, a transmembrane proteinNileena Velappan, Sofiya Micheva-Viteva, Samantha H Adikari, et al.
Mabs|November 2, 2020
Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors <i>in vivo</i>Lisa Nadal, Riccardo Corbellari, Alessandra Villa, et al.
Mabs|September 21, 2020
An accelerated surface-mediated stress assay of antibody instability for developability studiesMarie R G Kopp, Adriana-Michelle Wolf Pérez, Marta Virginia Zucca, et al.
Mabs|September 7, 2020
Engineered Fc-glycosylation switch to eliminate antibody effector functionQun Zhou, Julie Jaworski, Yanfeng Zhou, et al.
Mabs|January 7, 2020
Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptorXiaoshan Min, Junming Yie, Jinghong Wang, et al.
Mabs|March 20, 2020
Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumorsEric Hatterer, Xavier Chauchet, Françoise Richard, et al.
Mabs|March 14, 2020
Interaction analysis of glycoengineered antibodies with CD16a: a native mass spectrometry approachJoanna Hajduk, Cyrill Brunner, Sebastian Malik, et al.
Mabs|January 26, 2020
<i>In situ</i> antibody phage display yields optimal inhibitors of integrin α11/β1Eugenio Gallo, Abdellali Kelil, Peter E Bayliss, et al.
Pageof 184